Distribution of aluminum in different brain regions and body organs of rat

Biological Trace Element Research

Volumn 52, Issue 2, 1996, Pages 181-192

  Julka, D ^a   Vasishta, R K ^a   Gill, K D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Aluminum distribution; Alzheimer's disease; brain; dialysis encephalopathy; organs; rat; subcellular

Indexed keywords

ALUMINUM; TRACE ELEMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CELLULAR DISTRIBUTION; DIALYSATE; DIALYSIS; DISEASE ASSOCIATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; RAT;

ANIMALIA;

EID: 0029898452     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02789460     Document Type: Article

References (35)

1. D. R. Crapper-Mclachlan, S. S. Krishnan, and S. Quittkat, Aluminium, neurofibrillary degeneration and Alzheimer's disease, Brain 99, 67-80 (1976).
2. R. B. Winney, J. F. Cowie, and J. S. Robson, Role of plasma aluminium in the detection and prevention of aluminium toxicity, Kidney Int. 29, S91-S95 (1986).
3. A. B. Hodsman, D. J. Sherrard, A. C. Alfrey, S. Ott, A. S. Brickman, N. L. Miller, N. A. Maloney, and J. W. Coburn, Bone aluminium and histomorphometric features of renal osteodystrophy, J. Clin. Endocrinol Metab. 54, 539-546 (1982).
4. M. Hava and A. Hurwitz, The relaxing effect of aluminium and lanthanum on rat and human gastric smooth muscle in vitro, Eur. J. Pharmac. 22, 156-161 (1973).
5. G. L. Klein, M. B. Heyman, T. C. Lee, N. L. Miller, G. Marathe, W. K. Goorly, and A. C. Alfrey, Aluminium associated hepatobiliary dysfunction in rats: Relationship to dosage and duration of exposure, Ped. Res. 23, 275-280 (1988).
6. H. L. Elliott, A. I. MacDougall, G. S. Fell, and P. H. E. Gardiner, Plasmapheresis, aluminium and dialysis, Lancet ii, 1255 (1978).
7. C. G. Shaver and A. R. Riddel, Lung changes associated with the manufacture of alumina abrasives, J. Ind. Hyg. Toxicol 29, 147-157 (1947).
8. W. G. Goodman and O'Connor. Aluminium alters calcium influx and efflux from bone in vitro, Kidney Int. 39, 602-607 (1991).
9. G. C. Dunkley, Aluminium reduction in bladder cancer, Can. Med. Assoc. J. 126, 1026 (1982).
10. K. Sood, D. Nag, and S. V. Chandra, Role of aluminium in sporadic motor neuron disease, Ind. J. Med. Res. 92, 9-12 (1990).
11. R. M. Garruto and Y. Yase, Neurodegenerative disorders of the Western Pacific: the search for mechanisms of pathogenesis, Trends Neurosci. 9, 368 (1986).
12. J. Glowinski and L. L. Iversen, Regional studies of catecholamines in the rat brain, J. Neurochem. 13, 655-669 (1966).
13. L. Chavant, R. Dargent, J. Rami, and C. Mohant, Characterization of subcellular fractions, mitochondria and microsomes in two filamentous fungi, Biol. Cell 37, 299-303 (1980).
14. H. N. Munro and A. Fleck, The determination of nucleic acids, in Methods of Biochemical Analysis, vol. col. 14 D. Glick, ed., New York Interscience, New York, p. 113.
15. G. L. Sottocasa, B. Kuylenstierna, L. Ernster, and A. Bergstrand, An electron transport system associated with the outer membrane of liver mitochondria, J. Biol. Chem. 32, 415-438 (1967).
16. R. K. Crane and A. Sols, Animal tissue hexokinase, in Methods in Enzymology, Colowick, S. P. and Kaplan, N. O. eds., vol. 1, Academic, New York, pp. 277-282 (1965).
17. M. A. Swanson, Glucose-6-phosphatase from liver, in Methods in Enzymology vol. 2, Academic, New York, p. 541 (1955).
18. H. Zumkley, H. P. Bertram, A. Lison, O. Knoll, and H. Losse, Al, Zn and Cu concentrations in plasma in chronic renal insufficiency, Clin. Nephrol. 12, 18-21 (1979).
19. Y. Ebina, S. Okada, S. Hamazaki, and O. Midorikawa, Liver, Kidney and central nervous system toxicity of Al given intraperitoneally to rats: A multiple dose subchronic study using aluminium nitrilotriacetate, Toxicol. Appl. Pharma 75, 211-218 (1984).
20. S. K. Tandon and P. C. Tewari, Effect of co-exposure to ethanol and cadmium in rats, Bull. Environ. Contam. Toxicol. 39, 633-640 (1988).
21. P. O. Ganrot, Metabolism and possible health effects of aluminium, Environ. Health. Perspec. 65, 363-441 (1986).
22. J. C. K. Lai and J. P. Blass, Inhibition of brain glycolysis by aluminium, J. Neurochem., 42, 438-446 (1984).
23. G. B. Van der Voet and F. A. de Wolf, Intestinal absorption of aluminium in rats: Effects of intraluminal pH and aluminium concentration, J. Appl. Toxicol. 6, 37-41 (1987).
24. R. N. Martins, C. G. Harper, G. B. Stokes, and C. L. Masters, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J. Neurochem. 46, 1042-1045 (1986).
25. M. Cochran, J. Coates, and S. Neoh, The competitive equilibrium between aluminium and ferric ions for the binding sites of transferrin, FEBS Lett. 176, 129-132 (1987).
26. M. Cochran, D. C. Eliott, Pard. Brennan, and V. Chawtur, Inhibition of protein kinase C activation by low concentrations of aluminium, Clin. Chim Acta 194, 167-172 (1990).
27. A. J. Roskans and J. R. Connor, Aluminium access to the brain: A role for transferrin, and its receptor, Proc. Natl. Acad. Sci. 87, 9024-9027 (1990).
28. N. Seigal and A. Haug, Aluminium interaction with calmodulin: Evidence for altered structure and function from optical and enzymatic studies, Biochim. Biophys Acta 744, 36-45 (1983).
29. G. Du Val, B. R. Grubb, and P. J. Bentley, Tissue distribution of subcutaneously administered aluminium chloride in weanling rabbits, Toxicol. Environ. Health 19, 97-104 (1986).
30. M. Touam, F. Martinez, B. Locour, R. Bourdon, J. Zingraff, S. Cruilio, and T. Brueke, Aluminium induced reversible microcytic anemia in chronic renal failure clinical and experimental studies, Clin. Nephrol. 19, 295-298 (1983).
31. J. L. Greger and C. F. Powers, Assessment of exposure to parenterall and oral aluminium with and without citrate using a desferrioxamine test in rats. Toxicology 76, 119-132 (1992).
32. D. M. Holtzman and W. C. Mobley, Molecular studies in Alzheimer's disease, Trends Biochem. Sci. 16, 140-144 (1991).
33. World Health Organization, Principles and methods for the assessment of neurotoxicity associated with exposure to chemicals, in Environ. Health Criteria, Document 60, World Health Organization, Geneva.
34. M. K. Johnson, Organophosphorus esters causing delayed neurotoxic effect: Mechanism of action and structure/activity studies, Arch. Toxicol. 34, 259-288 (1975).
35. K. Katoh, Age related differences in the inhibition of neuropathy target esterase and susceptibility to triphenyl phosphite induced delayed neurotoxicity in chickens, Nippon. Eiseigaku Zasshi 47, 861-869 (1992).